Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
128
Publications
2242
Citations
74625
i10-index
789
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Vedolizumab as Induction and Maintenance Therapy f... | 2013 | 2566 |
STRIDE-II: An Update on the Selecting Therapeutic ... | 2021 | 1779 |
Selecting Therapeutic Targets in Inflammatory Bowe... | 2015 | 1623 |
The second European evidence-based Consensus on th... | 2010 | 1494 |
Tofacitinib as Induction and Maintenance Therapy f... | 2017 | 1472 |
Ulcerative colitis | 2020 | 1065 |
Epithelial NEMO links innate immunity to chronic i... | 2007 | 1034 |
Ulcerative Colitis | 2011 | 1001 |
Ustekinumab as Induction and Maintenance Therapy f... | 2019 | 958 |
Expanded allogeneic adipose-derived mesenchymal st... | 2016 | 910 |
Silvio Danese is a researcher with 2242 publications and 74625 citations. They are affiliated with Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele. Their research focuses on Medicine, Internal medicine, Pathology and other areas. With an h-index of 128, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Silvio Danese and 250M+ other papers.
Citations per publication by year